Record-setting summer temperatures across the globe are a metaphor for the financial heat being faced by large Pharma and the Pfizer-Mylan M&A is one answer to this problem. How their joint venture plans to spur sales in China, cut costs and streamline operations across the globe.
What The Pfizer-Mylan Deal Means For Pharma
